MX343653B - Síntesis de clorhidrato de metilfenidato a baja temperatura. - Google Patents

Síntesis de clorhidrato de metilfenidato a baja temperatura.

Info

Publication number
MX343653B
MX343653B MX2013007020A MX2013007020A MX343653B MX 343653 B MX343653 B MX 343653B MX 2013007020 A MX2013007020 A MX 2013007020A MX 2013007020 A MX2013007020 A MX 2013007020A MX 343653 B MX343653 B MX 343653B
Authority
MX
Mexico
Prior art keywords
low
methylphenidate hydrochloride
temperature synthesis
methylphenidate
hydrochloride
Prior art date
Application number
MX2013007020A
Other languages
English (en)
Other versions
MX2013007020A (es
Inventor
C Frederick M Huntley
Erik Wayne Kataisto
Lumiere Knicholaus Dudley La
Helge Alfred Reisch
Original Assignee
Rhodes Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodes Tech filed Critical Rhodes Tech
Publication of MX2013007020A publication Critical patent/MX2013007020A/es
Publication of MX343653B publication Critical patent/MX343653B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención describe un proceso para la preparación de clorhidrato de metilfenidato. El proceso implica la esterificación del ácido ritalínico y metanol en presencia de un catalizador ácido a una baja temperatura. El proceso puede involucrar opcionalmente la adición de un ortoéster.
MX2013007020A 2010-12-17 2011-12-16 Síntesis de clorhidrato de metilfenidato a baja temperatura. MX343653B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061424424P 2010-12-17 2010-12-17
PCT/IB2011/003140 WO2012080834A1 (en) 2010-12-17 2011-12-16 Low-temperature synthesis of methylphenidate hydrochloride

Publications (2)

Publication Number Publication Date
MX2013007020A MX2013007020A (es) 2014-11-10
MX343653B true MX343653B (es) 2016-11-07

Family

ID=45509554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007020A MX343653B (es) 2010-12-17 2011-12-16 Síntesis de clorhidrato de metilfenidato a baja temperatura.

Country Status (14)

Country Link
US (1) US9475770B2 (es)
EP (2) EP2937336A1 (es)
JP (1) JP5886869B2 (es)
KR (2) KR101561361B1 (es)
CN (1) CN103298785B (es)
AU (1) AU2011342894C1 (es)
BR (1) BR112013015072A2 (es)
CA (1) CA2822016C (es)
CO (1) CO6741202A2 (es)
ES (1) ES2542433T3 (es)
MX (1) MX343653B (es)
NZ (1) NZ612298A (es)
PH (1) PH12013501257A1 (es)
WO (1) WO2012080834A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014024203A1 (en) * 2012-08-07 2014-02-13 Zcl Chemicals Limited An improved process for - the preparation of dexmethylphenidate hydrochloride.
US9278928B2 (en) * 2012-11-29 2016-03-08 Zcl Chemicals Limited Process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof
JP2016535751A (ja) * 2013-11-08 2016-11-17 ノランコ・インコーポレーテツドＮｏｒａｍｃｏ Ｉｎｃｏｒｐｏｒａｔｅｄ メチルフェニデート及びその製薬学的塩の調製プロセス
US20170196846A1 (en) * 2014-06-06 2017-07-13 Rhodes Pharmaceuticals, L.P. Methods for treating attention deficit hyperactivity disorder with methylphenidate
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN104744342A (zh) * 2015-02-11 2015-07-01 河南中帅医药科技股份有限公司 盐酸右哌甲酯晶型及其制备方法
CN107325039B (zh) * 2016-04-29 2022-12-16 国药集团国瑞药业有限公司 一种盐酸右哌甲酯的制备方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN110698341A (zh) * 2019-10-24 2020-01-17 安庆博曼生物技术有限公司 丙炔酸衍生物的环保制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507631A (en) 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
US2838519A (en) 1953-12-23 1958-06-10 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4347374A (en) 1980-07-21 1982-08-31 Merck & Co., Inc. Acid addition salts of N-trityl-α-fluoromethylhistidine enantiomer derivatives
US5733756A (en) 1996-01-05 1998-03-31 Celgene Corporation Lactams and processes for stereoselective enrichment of lactams, amides, and esters
US6242464B1 (en) 1996-01-22 2001-06-05 Chiroscience Limited Single isomer methylphenidate and resolution process
GB9604943D0 (en) 1996-03-08 1996-05-08 Chiroscience Ltd Resolution
PL334136A1 (en) 1996-12-13 2000-02-14 Medeva Europ Ltd Method of obtaining enantiomerically enriched methyl threophenidate
GB9700912D0 (en) * 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US5936091A (en) 1997-05-22 1999-08-10 Celgene Corporation Processes and intermediates for resolving piperidyl acetamide stereoisomers
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
DE602004022633D1 (de) 2003-01-30 2009-10-01 Boehringer Ingelheim Pharma 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
CH712083B1 (de) 2003-02-05 2017-07-31 Siegfried Ag Verfahren zur Herstellung von d-threo-2-Phenyl-2-piperidin-2-yl-essigsäureestern.
US20050032873A1 (en) 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7229557B2 (en) 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
RU2468014C2 (ru) 2006-08-24 2012-11-27 Острэйлиен Ньюклиар Сайенс Энд Текнолоджи Организейшн Фторсодержащие лиганды для нацеливания периферических бензодиазепиновых рецепторов
US20100022446A1 (en) 2007-01-18 2010-01-28 Novo Nordisk A/S Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
WO2010080787A1 (en) * 2009-01-09 2010-07-15 Mallinckrodt Inc. Synthesis of methylphenidate and analogs thereof
WO2011067783A1 (en) 2009-12-01 2011-06-09 Harman Finochem Limited Process for preparing methyl phenidate hydrochloride

Also Published As

Publication number Publication date
NZ612298A (en) 2014-06-27
EP2651892A1 (en) 2013-10-23
KR20130115322A (ko) 2013-10-21
ES2542433T3 (es) 2015-08-05
US20150038720A1 (en) 2015-02-05
AU2011342894A1 (en) 2013-05-02
KR101561361B1 (ko) 2015-10-16
CO6741202A2 (es) 2013-08-30
BR112013015072A2 (pt) 2016-07-12
JP2014503530A (ja) 2014-02-13
CA2822016A1 (en) 2012-06-21
WO2012080834A8 (en) 2012-09-13
US9475770B2 (en) 2016-10-25
WO2012080834A1 (en) 2012-06-21
EP2937336A1 (en) 2015-10-28
AU2011342894B2 (en) 2015-05-07
CN103298785B (zh) 2016-04-20
AU2011342894C1 (en) 2015-07-30
PH12013501257A1 (en) 2022-03-30
MX2013007020A (es) 2014-11-10
CN103298785A (zh) 2013-09-11
CA2822016C (en) 2016-10-25
KR20150029769A (ko) 2015-03-18
JP5886869B2 (ja) 2016-03-16
EP2651892B1 (en) 2015-04-22

Similar Documents

Publication Publication Date Title
MX343653B (es) Síntesis de clorhidrato de metilfenidato a baja temperatura.
PY1212975A (es) Compuestos de azabiclo o quinuclidin-carbamato como inhibidores de glucosilceramida sintasa
BR112013025718A2 (pt) processos para produzir e resfriar gás de síntese
ES2829950T8 (es) Procedimiento para producir componentes endurecidos
DE102011014971A8 (de) Verbesserung des Fischer-Tropsch-Prozesses für die Kohlenwasserstoff-Kraftstoff-Formulierung
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
BR112013031019A2 (pt) teste diagnóstico molecular para câncer
BR112015000994A2 (pt) processo e sistema de reação para a preparação de metanol
BR112013015395A2 (pt) processo para preparar ácido fórmico
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112014013862A2 (pt) processos incluindo de alta produtividade, para fermentar gás de síntese
BR112013021775A2 (pt) bactéria corineforme, e, método para produzir um l-aminoácido
ES1073581Y (es) Soporte para aparatos reproductores audio-visuales.
BR112014007306A2 (pt) artigos extrudados homogêneos feitos a partir de poliuretanos termoplasticamente processáveis com base em poliéster-dióis formados a partir de ácido succínico e de 1,3-propanodiol
BR112012004482A2 (pt) "método para produzir um l-aminoácido"
BR112013015964A2 (pt) aperfeiçoamento para reatores mecano-químicos.
MX394430B (es) Proceso para la preparación de 5-fluoro-1h-pirazoles.
CO6592111A2 (es) Procedimiento de activación y conjugación de biomoleculas
BRPI1007069A2 (pt) Método para produzir um l-aminoácido.
IT1397886B1 (it) Procedimento per la produzione di componenti di carburanti per autotrazione.
WO2012174229A3 (en) Methods for the synthesis and purification of deoxycholic acid
WO2012170098A3 (en) Arbovirus inhibitors and uses thereof
BR112014007818A2 (pt) co-cultura sintrófica de micro-organismos anaeróbicos para a produção de n-butanol a partir de gás de síntese
BR112013010726A2 (pt) composição, formulação líquida, alimentação, e métodos para inibir reação de descarboxilação de ácido anacárdico e para produzir formulação líquida
MX2015005510A (es) Forma salina solida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.

Legal Events

Date Code Title Description
FG Grant or registration